The global hospital acquired disease testing market size reached around USD 1609.43 Million in 2024. The market is projected to grow at a CAGR of 16.40% between 2025 and 2034 to reach nearly USD 7348.55 Million by 2034.
Base Year
Historical Year
Forecast Year
Value in USD Million
2025-2034
Hospital Acquired Disease Testing Market Outlook
*this image is indicative*
On the basis of the indication, the urinary tract infection segment is estimated to be the largest indication segment. The segment growth is primarily attributed to the rising incidences of immune suppression accompanied by urologic abnormality due to the consumption of unhealthy food, alcohol, and smoking.
Regionally, North America is anticipated to dominate the market in 2020, owing to the increasing reimbursement policies and favourable government initiatives towards hospital acquired (nosocomial) infections.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
A hospital acquired infection (HAI) or diseases or nosocomial infection is an infection which is acquired from the hospital or the clinical surrounding including nursing homes, and rehabilitation centres, among others. The incubation period of the nosocomial infection generally varies between 48 hours to 4 days. The prime reason behind the cause of HAI is the lack of proper hygiene in the hospital or clinical environment by the internal staff. Also, other factors that can be attributed to the growth of HAI include below-par maintenance, complacency by the hospital staff, and a rise in multi-drug resistant organisms (MDROs). Some of the commonly occurring nosocomial infections include pneumonia, urinary tract infections (UTI), and primary bloodstream infections.
On the basis of indication, the market is segmented into:
The EMR report looks into the regional markets of hospital acquired disease testing like:
With the increasing global population, rapid urbanisation, and modernisation of healthcare infrastructure, there has been a significant increase in the number of health care facilities. This has led to the rising incidence of HAIs, which, in turn, is propelling the demand for hospital acquired disease tests. The rising adoption of advanced technologies for preventing, diagnosing, and monitoring HAIs, such as microarrays, polymerase chain reaction (PCR), real time location systems (RTLSs), and solid phase hybridisation, is further expected to augment the market growth.
Moreover, the growing awareness of HAIs among patients and stringent government regulations to penalize hospitals with a high incidence of HAIs are some of the other factors that are strengthening the growth of the market. Increasing research and development activities for developing new techniques, coupled with various mergers and acquisitions and strategic partnerships by various manufacturers, are expected to create potential revenue opportunities for players operating in the market over the forecast period.
The report presents a detailed analysis of the following key players in the global hospital acquired disease testing market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2024, the market reached an approximate value of USD 1609.43 Million.
The market is projected to grow at a CAGR of 16.40% between 2025 and 2034.
The market is estimated to witness healthy growth in the forecast period of 2025-2034 to reach a value of around USD 7348.55 Million by 2034.
The major drivers of the market include the increasing incidences of immune suppression, the introduction of favourable government initiatives aimed at increasing reimbursement policies towards hospital acquired diseases, and growing global population.
The modernisation of healthcare, the rising adoption of advanced technologies for preventing, diagnosing, and treating hospital acquired diseases, growing awareness regarding hospital acquired diseases among patients, and increasing research activities to develop advanced diagnostic technologies are the key trends guiding the market.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant indication segments considered in the market report include UTI (urinary tract infection), SSI (surgical site infection), pneumonia, bloodstream infections, and MRSA (methicillin-resistant staphylococcus aureus), among others.
The major players in the market are Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Hologic, Inc., and Siemens Healthcare GmbH, among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Indication |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share